129 related articles for article (PubMed ID: 2636662)
1. Correction of amino acid metabolism by recombinant human erythropoietin therapy in hemodialysis patients.
Riedel E; Hampl H; Scigalla P; Nündel M; Kessel M
Kidney Int Suppl; 1989 Nov; 27():S216-21. PubMed ID: 2636662
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin (rhEPO) treatment potentiates growth hormone (GH) response to growth hormone releasing hormone (GHRH) stimulation in hemodialysis patients.
Cremagnani L; Cantalamessa L; Orsatti A; Vigna L; Vallino F; Buccianti G
Clin Nephrol; 1993 May; 39(5):282-6. PubMed ID: 8513607
[TBL] [Abstract][Full Text] [Related]
3. In vivo effects of recombinant human erythropoietin on bone marrow hematopoiesis in patients with chronic renal failure.
Biljanović-Paunović L; Djukanović L; Lezaić V; Stojanović N; Marisavljević D; Pavlović-Kentera V
Eur J Med Res; 1998 Dec; 3(12):564-70. PubMed ID: 9889177
[TBL] [Abstract][Full Text] [Related]
4. Effect of recombinant human erythropoietin on the anemia of chronic renal failure.
Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S
Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592
[TBL] [Abstract][Full Text] [Related]
5. Echocardiographic findings in patients on maintenance hemodialysis substituted with recombinant human erythropoietin.
Löw I; Grützmacher P; Bergmann M; Schoeppe W
Clin Nephrol; 1989 Jan; 31(1):26-30. PubMed ID: 2521587
[TBL] [Abstract][Full Text] [Related]
6. Effect of recombinant human erythropoietin (rHuEpo) on the hemostatic system in chronic hemodialysis patients.
Huraib S; al-Momen AK; Gader AM; Mitwalli A; Sulimani F; Abu-Aisha H
Clin Nephrol; 1991 Nov; 36(5):252-7. PubMed ID: 1752076
[TBL] [Abstract][Full Text] [Related]
7. Amino acid and alpha-keto acid metabolism depends on oxygen availability in chronic hemodialysis patients.
Riedel E; Nündel M; Wendel G; Hampl H
Clin Nephrol; 2000 Feb; 53(1 Suppl):S56-60. PubMed ID: 10746807
[TBL] [Abstract][Full Text] [Related]
8. Human recombinant erythropoietin treatment in transfusion dependent anemic patients on maintenance hemodialysis.
Zehnder C; Blumberg A
Clin Nephrol; 1989 Feb; 31(2):55-9. PubMed ID: 2920469
[TBL] [Abstract][Full Text] [Related]
9. Nutritional assessment in anemic hemodialysis patients treated with recombinant human erythropoietin.
Bárány P; Pettersson E; Ahlberg M; Hultman E; Bergström J
Clin Nephrol; 1991 Jun; 35(6):270-9. PubMed ID: 1873941
[TBL] [Abstract][Full Text] [Related]
10. Effects of erythropoietin on glucose tolerance in hemodialysis patients.
Chagnac A; Weinstein T; Zevin D; Korzets A; Hirsh J; Gafter U; Levi J
Clin Nephrol; 1994 Dec; 42(6):398-400. PubMed ID: 7882604
[TBL] [Abstract][Full Text] [Related]
11. Effects of recombinant human erythropoietin on hematopoietic progenitors of chronic hemodialysis patients in vitro and in vivo.
Hino M; Miyazono K; Urabe A; Takaku F
Int J Cell Cloning; 1989 Jul; 7(4):257-63. PubMed ID: 2768843
[TBL] [Abstract][Full Text] [Related]
12. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Li H; Wang SX
Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
[TBL] [Abstract][Full Text] [Related]
13. Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin.
Silberberg J; Racine N; Barre P; Sniderman AD
Can J Cardiol; 1990; 6(1):1-4. PubMed ID: 2138048
[TBL] [Abstract][Full Text] [Related]
14. [The effect of long term erythropoietin treatment on levels of free amino acids in patients with long term hemodialysis].
Boratyńska M; Boratyński J; Magott M; Szewczyk Z
Przegl Lek; 1996; 53(5):398-401. PubMed ID: 8754400
[TBL] [Abstract][Full Text] [Related]
15. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
Nakamoto H; Mimura T; Honda N
Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
[TBL] [Abstract][Full Text] [Related]
16. Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis.
Chuang CK; Lin SP; Chen HH; Chen YC; Wang TJ; Shieh WH; Wu CJ
Clin Chim Acta; 2006 Feb; 364(1-2):209-16. PubMed ID: 16087168
[TBL] [Abstract][Full Text] [Related]
17. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
Stojimirović B; Grujić-Adanja G
Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects on lymphocytotoxic antibodies and immune reactivity in hemodialysis patients treated with recombinant human erythropoietin.
Bárány P; Fehrman I; Godoy C
Clin Nephrol; 1992 Feb; 37(2):90-6. PubMed ID: 1551255
[TBL] [Abstract][Full Text] [Related]
19. Effects of erythropoietin on strength and functional status of patients on hemodialysis.
Guthrie M; Cardenas D; Eschbach JW; Haley NR; Robertson HT; Evans RW
Clin Nephrol; 1993 Feb; 39(2):97-102. PubMed ID: 8448925
[TBL] [Abstract][Full Text] [Related]
20. Complete correction of renal anemia by recombinant human erythropoietin.
Ludat K; Paulitschke M; Riedel E; Hampl H
Clin Nephrol; 2000 Feb; 53(1 Suppl):S42-9. PubMed ID: 10746805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]